Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TECH | BMRN | SRPT | ||
| Company | Bio-Techne Corp | Biomarin Pharmaceuticals | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 71.25 | 64.90 | 119.59 | ||
| High | 74.27 | 66.27 | 121.00 | ||
| Low | 71.25 | 64.07 | 118.56 | ||
| Last | 73.17 | 65.66 | 118.97 | ||
| Change | +1.78 | +0.66 | -0.50 | ||
| % Change | +2.49% | +1.02% | -0.42% | ||
| Volume | 2,221,100 | 3,974,300 | 1,952,900 | ||
| 20-Day Average Volume | 795,410 | 1,602,505 | 1,081,915 | ||
| Previous Close | 71.39 | 65.00 | 119.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 74.89 | 65.64 | 125.31 | ||
| 20-Day Raw Stochastic | 41.28% | 56.06% | 29.92% | ||
| 20-Day Relative Strength | 48.14% | 46.78% | 45.30% | ||
| Weighted Alpha | -4.97 | -32.95 | +1.64 | ||
| Today's Opinion | 24% Sell | 88% Sell | 72% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.33% since 12/13/24 | -0.53% since 12/13/24 | -3.83% since 12/13/24 | ||
| Low | 69.48 on 12/19/24 | 63.93 on 12/19/24 | 117.97 on 12/19/24 | ||
| High | 77.62 on 12/17/24 | 67.85 on 12/17/24 | 128.73 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +6.48% since 11/20/24 | +4.96% since 11/20/24 | +7.32% since 11/20/24 | ||
| Low | 68.42 on 11/21/24 | 61.41 on 11/21/24 | 109.03 on 11/21/24 | ||
| High | 78.42 on 12/11/24 | 67.87 on 12/09/24 | 138.81 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | -6.55% since 09/20/24 | -7.12% since 09/20/24 | -6.48% since 09/20/24 | ||
| Low | 65.61 on 11/20/24 | 61.15 on 11/19/24 | 102.15 on 11/18/24 | ||
| High | 80.80 on 11/06/24 | 71.24 on 09/30/24 | 138.81 on 11/29/24 | ||
| 6-Month | |||||
| %Chg | -1.82% since 06/20/24 | -22.49% since 06/20/24 | -3.67% since 06/20/24 | ||
| Low | 65.61 on 11/20/24 | 61.15 on 11/19/24 | 102.15 on 11/18/24 | ||
| High | 83.62 on 07/31/24 | 94.85 on 08/20/24 | 173.25 on 06/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,626,126 | 12,513,680 | 11,364,014 | ||
| Shares Outstanding, K | 158,892 | 190,583 | 95,520 | ||
| Annual Sales | 1,159,060,000 | 2,419,230,000 | 1,243,340,000 | ||
| Annual Net Income | 168,110,000 | 167,650,000 | -535,980,000 | ||
| Last Quarter Sales | 289,460,000 | 745,740,000 | 467,170,000 | ||
| Last Quarter Net Income | 33,600,000 | 106,080,000 | 33,610,000 | ||
| 60-Month Beta | 1.27 | 0.29 | 0.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 10/30/24 | 0.91 on 10/29/24 | 0.62 on 11/06/24 | ||
| Latest Earnings Date | 02/06/25 | 10/29/24 | 11/06/24 | ||
| Most Recent Dividend | 0.080 on 11/08/24 | N/A | N/A | ||
| Next Ex-Dividends Date | 11/08/24 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 43.80 | 28.76 | 102.99 | ||